
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>complement binding antibodies and 1:16 serum dilution</title>
<link>https://www.ashi-hla.org/forums/posts.aspx?topic=1349617</link>
<description></description>
<lastBuildDate>Sat, 6 Jun 2026 11:57:04 GMT</lastBuildDate>
<pubDate>Fri, 7 Apr 2017 12:34:33 GMT</pubDate>
<copyright>Copyright &#xA9; 2017 American Society for Histocompatibility and Immunogenetics</copyright>
<atom:link href="https://www.ashi-hla.org/forums/topic_rss.asp?id=1349617" rel="self" type="application/rss+xml"></atom:link>
<item>
<title>complement binding antibodies and 1:16 serum dilution</title>
<link>https://www.ashi-hla.org/forums/posts.aspx?topic=1349617</link>
<guid>https://www.ashi-hla.org/forums/posts.aspx?topic=1349617</guid>
<description><![CDATA[<p>Dear Colleagues:</p>
<p>&nbsp;</p>
<p>The use of single antigen testing for complement-fixing antibodies has been controversial in the past. Does your experience indicate that this testing is clinically useful? One of our transplant nephrologists is advocating that instead of a complement-fixing single antigen bead assay, we simply test the serum at a 1:16 dilution. Can anyone recommend that? Is there credible support in the literature? Thank you so much!</p>
<p>&nbsp;</p>
<p>Best wishes,</p>
<p>&nbsp;</p>
<p>Charlie Lutz</p>]]></description>
<pubDate>Fri, 7 Apr 2017 13:34:33 GMT</pubDate>
</item>
</channel>
</rss>
